Vincerx Pharma, Inc.
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibit…
Biotechnology
US, Palo Alto [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Vincerx Pharma, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDVincerx Pharma, Inc. can't present revenue by segment